Pharmed Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 23-10-2024
- Paid Up Capital ₹ 8.61 M
as on 23-10-2024
- Company Age 78 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 21.22%
(FY 2023)
- Profit -21.79%
(FY 2023)
- Ebitda -23.45%
(FY 2023)
- Net Worth 15.98%
(FY 2023)
- Total Assets 10.64%
(FY 2023)
About Pharmed
The Corporate was formerly known as Pharmed Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 8.61 M, as per Ministry of Corporate Affairs (MCA) records.
Santhanam Narayanaswamy, Satyanarayan Agarwal, Yogesh Aurora, and Seven other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1946PLC005121
- Company No.
005121
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Aug 1946
- Date of AGM
18 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Pharmed Limited offer?
Pharmed Limited offers a wide range of products and services, including Multivitamin Syrup & Drops, Antioxidant Syrup, Multivitamin Tablets & Capsules, Vitamin B Complex Tablets & Capsules, Pharmaceutical Tablets, Pharmaceutical Syrup, Pharmaceutical Medicine, Pharmaceutical Products, Pain Reliever Gel, Diclofenac Diethylamine Gel.
Who are the key members and board of directors at Pharmed?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suneet Aurora  | Managing Director | 01-Aug-2008 | Current |
Board Members(9)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Roop Khar | Director | 26-Aug-2024 | Current |
| Santhanam Narayanaswamy | Director | 26-Aug-2024 | Current |
| Jagadish Chinnappa | Director | 25-Jun-2014 | Current |
| Satyanarayan Agarwal | Director | 16-May-2013 | Current |
| Yogesh Aurora | Whole-Time Director | 30-Jun-2020 | Current |
| Krishnamurthy Venkataramani | Whole-Time Director | 06-May-2008 | Current |
Financial Performance and Corporate Structure Insights of Pharmed.
Pharmed Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.22% increase. The company also saw a substantial fall in profitability, with a 21.79% decrease in profit. The company's net worth Soared by an impressive increase of 15.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmed?
In 2023, Pharmed had a promoter holding of 91.77% and a public holding of 8.23%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pharmed Medicare Private LimitedActive 34 years 8 monthsYogesh Aurora and Krishan Aurora are mutual person
Bhoruka Agro Business Private LimitedActive 25 years 9 monthsSatyanarayan Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmed?
Pharmed has a workforce of 1473 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
